表紙
市場調査レポート

微生物検査/臨床微生物学の世界市場予測 2021年:呼吸器疾患・血流感染症・消化管疾患・性感染症 (STD)・尿路感染症 (UTI)・歯周病

Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product - Global Forecasts to 2021

発行 MarketsandMarkets 商品コード 322916
出版日 ページ情報 英文 202 Pages
即納可能
価格
本日の銀行送金レート: 1USD=102.12円で換算しております。
Back to Top
微生物検査/臨床微生物学の世界市場予測 2021年:呼吸器疾患・血流感染症・消化管疾患・性感染症 (STD)・尿路感染症 (UTI)・歯周病 Microbiology Testing/Clinical Microbiology Market by Microbiology Application (Pharmaceutical, Clinical, Manufacturing, Energy), Clinical Application (Respiratory Diseases, STD, UTI), Product - Global Forecasts to 2021
出版日: 2016年06月03日 ページ情報: 英文 202 Pages
概要

世界の臨床微生物学市場は、2016年の33億5,000万米ドルから2021年までに57億7,000万米ドルに達すると予測され、2016年から2021年にかけては11.5%のCAGR (年間複合成長率) が見込まれています。同市場の成長は、技術進歩、感染症罹患率の上昇と伝染病発生の増加、世界的な医療費の増加、およびライフサイエンス研究分野における財政的支援・研究助成金・官民投資の拡大といった要因に起因しています。

当レポートでは、世界の微生物検査/臨床微生物学市場について詳細に調査分析し、用途、製品、疾病分野および地域別の動向、市場影響因子と市場機会の分析、競合環境と市場シェア、および主要事業者のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 世界の微生物検査市場
  • 世界の微生物検査市場:用途別
  • 世界の臨床微生物学市場
  • 臨床微生物学製品市場のシェア:地域別
  • 世界の臨床微生物学製品市場:地域別
  • 世界の臨床微生物学市場:疾病分野別
  • 世界の臨床微生物学市場:国別
  • 世界の臨床微生物学市場における収益性の高い市場機会
  • ライフサイクル分析:地域別

第5章 市場概要

  • イントロダクション
  • 市場区分
  • 市場ダイナミクス
    • 主な市場成長促進因子
    • 主な市場成長抑制因子
    • 主な市場機会
    • 主な市場課題

第6章 産業考察

  • イントロダクション
  • バリューチェーン分析
    • 臨床微生物学装置
    • 臨床微生物学試薬・キット
  • 主な産業の重点領域
    • 分子診断プロセスを用いた先進技術の統合
    • 臨床検査技術の自動化の進行
  • ポーターのファイブフォース分析

第7章 臨床微生物学市場:製品別

  • イントロダクション
  • 器具
    • ラボ用器具
    • 微生物アナライザー
  • 試薬
    • 病原体専用キット
    • 一般的な試薬

第8章 臨床微生物学市場:用途別

  • イントロダクション
  • 医薬品
  • 臨床
  • 食品検査
  • エネルギー
  • 化学・金属製造
  • 環境

第9章 臨床微生物学市場:疾病分野別

  • イントロダクション
  • 呼吸器疾患
  • 血流感染症
  • 消化管疾患
  • 性感染症
  • 尿路感染症
  • 歯周病
  • その他の疾患

第10章 微生物検査/臨床微生物学市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • 英国
    • フランス
    • その他の欧州 (ROE)
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • その他のアジア太平洋
  • その他の地域 (ROW)

第11章 競合情勢

  • 概要
  • 市場シェア分析:主要企業別
  • 競合状況

第12章 企業プロファイル (イントロダクション・製品 & サービス・戦略 & アナリストの考察・発展動向・MNMの見解)

  • イントロダクション
  • BIOMERIEUX S.A.
  • DANAHER CORPORATION
  • BECTON, DICKINSON AND COMPANY
  • CEPHEID (米国)
  • ABBOTT LABORATORIES, INC.
  • ALERE, INC.
  • BIO-RAD LABORATORIES INC.
  • F. HOFFMAN-LA ROCHE LTD.
  • BRUKER CORPORATION
  • HOLOGIC, INC.

第13章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3092

The global clinical microbiology market is projected to reach USD 5.77 billion by 2021 from USD 3.35 billion in 2016, growing at a CAGR of 11.5%, during 2016 to 2021. Market growth can be attributed to factors such as the technological advancements; rising incidence of infectious diseases and growing outbreak of epidemics; growing healthcare expenditure across the world; and increasing funding, research grants, and public-private investments in the field of life science researches. However, reimbursement concerns and unfavorable regulatory scenario are restraining the growth of the clinical microbiology market. Furthermore, improving healthcare infrastructure across the emerging markets and growing market demand for advanced molecular diagnostic products provide various opportunities in the clinical microbiology market. The operational barriers for diagnostic test usage and bundled sales by market giants across major markets are the major challenges limiting the growth of the global clinical microbiology market to a certain extent.

In this report, the global clinical microbiology market is segmented on the basis of product into instruments [laboratory instruments (incubators, gram strainers, bacterial colony counters, autoclave sterilizers, microbial air samplers, anaerobic culture systems, petridish fillers, blood culture systems, microbial culture systems, and other laboratory instruments) and microbiology analyzers (molecular diagnostic instruments, microscopes, and mass spectrometers)] and reagents (pathogen specific kits and general reagents).

Geographically, North America and Europe are expected to be the mature markets for clinical microbiology products in 2016. The North American clinical microbiology market is expected to hold the largest share of global clinical microbiology market in 2016. However, the Asia-Pacific clinical microbiology market is projected to grow at the highest CAGR during the forecast period owing to the growing number of hospitals and clinical diagnostic laboratories in India and China; expanding research capabilities for the development of innovative and affordable clinical microbiology testing procedures across India, China, and Japan; and rising incidences of infectious diseases.

Leading players in the clinical microbiology market include bioMerieux S.A. (France), Danaher Corporation (U.S.), Becton, Dickinson and Company (U.S.), Cepheid (U.S.) Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffman-La Roche Ltd. (Switzerland), Alere Inc. (U.S.), Bruker Corporation (U.S.), and Hologic, Inc. (U.S.).

Reasons to Buy the Report:

From an insight perspective, this research report has focused on various levels of analysis such as market share analysis of the top ten players and company profiles, which together comprise and discuss the basic views on the competitive landscape, emerging and high-growth segments of the clinical microbiology market, and high-growth regions and their respective drivers, restraints, challenges, and opportunities.

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn help firms to garner a higher market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the clinical microbiology products offered by the top 10 players in the global market. The report analyzes the clinical microbiology market by products and disease area across key geographic regions
  • Product Development/Innovation: Detailed insights on the upcoming clinical microbiology products, research and development activities, and new product launches in the market
  • Market Development: Comprehensive information on the lucrative emerging markets. The report analyzes the markets for various clinical microbiology products across key geographic regions
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the global clinical microbiology market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of leading players in the global clinical microbiology market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. GEOGRAPHIC SCOPE
    • 1.3.3. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY AND PRICING
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH DATA
    • 2.1.1. SECONDARY DATA
      • 2.1.1.1. Key data from secondary sources
    • 2.1.2. PRIMARY DATA
      • 2.1.2.1. Key data from primary sources
    • 2.1.3. BREAKDOWN OF PRIMARIES
  • 2.2. OPPORTUNITY INDICATORS
    • 2.2.1. INTRODUCTION
    • 2.2.2. DEMAND-SIDE ANALYSIS
      • 2.2.2.1. Burden of infectious diseases
      • 2.2.2.2. Healthcare expenditure patterns
      • 2.2.2.3. Rapid growth in geriatric population
      • 2.2.2.4. Increasing number of clinical researches in the field of clinical microbiology
    • 2.2.3. SUPPLY-SIDE ANALYSIS
      • 2.2.3.1. Parent market analysis: Life science products market
      • 2.2.3.2. Number of new product launches: clinical microbiology products
  • 2.3. MARKET SIZE ESTIMATION
    • 2.3.1. BOTTOM-UP APPROACH
    • 2.3.2. TOP-DOWN APPROACH
  • 2.4. MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.5. ASSUMPTIONS

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. GLOBAL MICROBIOLOGY TESTING MARKET (2016-2021)
  • 4.2. GLOBAL MICROBIOLOGY TESTING MARKET, BY APPLICATION (2016-2021)
  • 4.3. GLOBAL CLINICAL MICROBIOLOGY MARKET (2016-2021)
  • 4.4. CLINICAL MICROBIOLOGY PRODUCTS MARKET SHARE, BY REGION (2016)
  • 4.5. GLOBAL CLINICAL MICROBIOLOGY PRODUCTS MARKET, BY REGION (2016-2021)
  • 4.6. GLOBAL CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA (2016-2021)
  • 4.7. GLOBAL CLINICAL MICROBIOLOGY MARKET, BY COUNTRY (2016-2021)

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. KEY MARKET DRIVERS
      • 5.3.1.1. Technological advancements
      • 5.3.1.2. Rising incidence of infectious diseases and growing outbreaks of epidemics
      • 5.3.1.3. Increased funding, research grants, and public-private investments
    • 5.3.2. KEY MARKET RESTRAINTS
      • 5.3.2.1. Reimbursement concerns
      • 5.3.2.2. Unfavorable regulatory scenario
    • 5.3.3. KEY MARKET OPPORTUNITIES
      • 5.3.3.1. Growing market demand for advanced molecular diagnostic products
      • 5.3.3.2. Improving healthcare infrastructure across emerging countries
    • 5.3.4. KEY MARKET CHALLENGES
      • 5.3.4.1. Operational barriers related to usage of diagnostic tests
      • 5.3.4.2. Bundled sales by market giants - A key challenge for small and emerging reagent manufacturers

6. INDUSTRY INSIGHTS

  • 6.1. INTRODUCTION
  • 6.2. VALUE CHAIN ANALYSIS
    • 6.2.1. CLINICAL MICROBIOLOGY INSTRUMENTS
    • 6.2.2. CLINICAL MICROBIOLOGY REAGENTS AND KITS
  • 6.3. KEY INDUSTRY FOCUS AREAS
    • 6.3.1. INTEGRATION OF ADVANCED TECHNOLOGIES WITH MOLECULAR DIAGNOSTIC PROCESSES
    • 6.3.2. ONGOING AUTOMATION OF CLINICAL LABORATORY TECHNIQUES
  • 6.4. PORTER'S FIVE FORCES ANALYSIS
    • 6.4.1. THREAT FROM NEW ENTRANTS
    • 6.4.2. THREAT FROM SUBSTITUTES
    • 6.4.3. BARGAINING POWER OF SUPPLIERS
    • 6.4.4. BARGAINING POWER OF BUYERS
    • 6.4.5. INTENSITY OF COMPETITIVE RIVALRY

7. CLINICAL MICROBIOLOGY MARKET, BY PRODUCT

  • 7.1. INTRODUCTION
  • 7.2. INSTRUMENTS
    • 7.2.1. LABORATORY INSTRUMENTS
      • 7.2.1.1. Incubators
      • 7.2.1.2. Gram Stainers
      • 7.2.1.3. Bacterial Colony Counters
      • 7.2.1.4. Autoclave Sterilizers
      • 7.2.1.5. Microbial Air Samplers
      • 7.2.1.6. Anaerobic Culture Systems
      • 7.2.1.7. Petri Dish Fillers
      • 7.2.1.8. Blood Culture Systems
      • 7.2.1.9. Microbial Culture Systems
      • 7.2.1.10. Other Laboratory Instruments
    • 7.2.2. MICROBIOLOGY ANALYZERS
      • 7.2.2.1. Molecular Diagnostic Instruments
      • 7.2.2.2. Microscopes
      • 7.2.2.3. Mass Spectrometers
  • 7.3. REAGENTS
    • 7.3.1. PATHOGEN-SPECIFIC KITS
    • 7.3.2. GENERAL REAGENTS

8. MICROBIOLOGY TESTING MARKET, BY APPLICATION

  • 8.1. INTRODUCTION
  • 8.2. PHARMACEUTICAL APPLICATIONS
  • 8.3. CLINICAL APPLICATIONS
  • 8.4. FOOD TESTING APPLICATIONS
  • 8.5. ENERGY APPLICATIONS
  • 8.6. CHEMICAL AND MATERIAL MANUFACTURING APPLICATIONS
  • 8.7. ENVIRONMENTAL APPLICATIONS

9. CLINICAL MICROBIOLOGY MARKET, BY DISEASE AREA

  • 9.1. INTRODUCTION
  • 9.2. RESPIRATORY DISEASES
  • 9.3. BLOODSTREAM INFECTIONS
  • 9.4. GASTROINTESTINAL DISEASES
  • 9.5. SEXUALLY TRANSMITTED DISEASES
  • 9.6. URINARY TRACT INFECTIONS
  • 9.7. PERIODONTAL DISEASES
  • 9.8. OTHER DISEASES

10. MICROBIOLOGY TESTING/CLINICAL MICROBIOLOGY MARKET, BY REGION

  • 10.1. INTRODUCTION
  • 10.2. NORTH AMERICA
    • 10.2.1. U.S.
    • 10.2.2. CANADA
  • 10.3. EUROPE
    • 10.3.1. GERMANY
    • 10.3.2. U.K.
    • 10.3.3. FRANCE
    • 10.3.4. REST OF EUROPE (ROE)
  • 10.4. ASIA-PACIFIC
    • 10.4.1. JAPAN
    • 10.4.2. CHINA
    • 10.4.3. INDIA
    • 10.4.4. REST OF ASIA-PACIFIC (ROAPAC)
  • 10.5. REST OF THE WORLD (ROW)

11. COMPETITIVE LANDSCAPE

  • 11.1. OVERVIEW
  • 11.2. MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
  • 11.3. COMPETITIVE SCENARIO
    • 11.3.1. PRODUCT APPROVALS, LAUNCHES, AND ENHANCEMENTS
    • 11.3.2. AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
    • 11.3.3. ACQUISITIONS
    • 11.3.4. EXPANSIONS

12. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 12.1. INTRODUCTION
    • 12.1.1. GEOGRAPHIC BENCHMARKING
  • 12.2. BIOMERIEUX S.A.
  • 12.3. DANAHER CORPORATION
  • 12.4. BECTON, DICKINSON AND COMPANY
  • 12.5. CEPHEID (U.S.)
  • 12.6. ABBOTT LABORATORIES, INC.
  • 12.7. ALERE, INC.
  • 12.8. BIO-RAD LABORATORIES INC.
  • 12.9. F. HOFFMAN-LA ROCHE LTD.
  • 12.10. BRUKER CORPORATION
  • 12.11. HOLOGIC, INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

13. APPENDIX

  • 13.1. INSIGHTS OF INDUSTRY EXPERTS
  • 13.2. DISCUSSION GUIDE
  • 13.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 13.5. AVAILABLE CUSTOMIZATIONS
  • 13.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 2: GLOBAL CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 3: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 4: GLOBAL CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 5: CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: INCUBATORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 7: GRAM STAINERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: BACTERIAL COLONY COUNTERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 9: AUTOCLAVE STERILIZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: MICROBIAL AIR SAMPLERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 11: ANAEROBIC CULTURE SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 12: PETRI DISH FILLERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: BLOOD CULTURE SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 14: MICROBIAL CULTURE SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: OTHER LABORATORY INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL MICROBIOLOGY ANALYZERS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 17: MICROBIOLOGY ANALYZERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 18: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: MICROSCOPES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 20: MASS SPECTROMETERS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: GLOBAL CLINICAL MICROBIOLOGY REAGENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 22: CLINICAL MICROBIOLOGY REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 23: PATHOGEN-SPECIFIC KITS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: GENERAL REAGENTS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 25: GLOBAL MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 26: MICROBIOLOGY TESTING MARKET SIZE FOR PHARMACEUTICAL APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: MICROBIOLOGY TESTING MARKET SIZE FOR CLINICAL APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 28: MICROBIOLOGY TESTING MARKET SIZE FOR FOOD TESTING APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 29: MICROBIOLOGY TESTING MARKET SIZE FOR ENERGY APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 30: MICROBIOLOGY TESTING MARKET SIZE FOR CHEMICAL AND MATERIAL MANUFACTURING APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 31: MICROBIOLOGY TESTING MARKET SIZE FOR ENVIRONMENTAL APPLICATIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 32: GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DISEASE AREA, 2014-2021 (USD MILLION)
  • TABLE 33: CLINICAL MICROBIOLOGY MARKET SIZE FOR RESPIRATORY DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 34: CLINICAL MICROBIOLOGY MARKET SIZE FOR BLOODSTREAM INFECTIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: CLINICAL MICROBIOLOGY MARKET SIZE FOR GASTROINTESTINAL DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 36: CLINICAL MICROBIOLOGY MARKET SIZE FOR SEXUALLY TRANSMITTED DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 37: CLINICAL MICROBIOLOGY MARKET SIZE FOR URINARY TRACT INFECTIONS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 38: CLINICAL MICROBIOLOGY MARKET SIZE FOR PERIODONTAL DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: CLINICAL MICROBIOLOGY MARKET SIZE FOR OTHER DISEASES, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 40: MICROBIOLOGY TESTING MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: CLINICAL MICROBIOLOGY MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 42: NORTH AMERICA: MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 43: NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 44: NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 45: NORTH AMERICA: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 46: NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SIZE, BY DISEASE AREA, 2014-2021 (USD MILLION)
  • TABLE 47: U.S.: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 48: CANADA: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 49: EUROPE: MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 50: EUROPE: CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 51: EUROPE: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 52: EUROPE: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: EUROPE: CLINICAL MICROBIOLOGY MARKET SIZE, BY DISEASE AREA, 2014-2021 (USD MILLION)
  • TABLE 54: GERMANY: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 55: U.K.: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 56: FRANCE: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 57: ROE: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 58: ASIA-PACIFIC: MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 59: ASIA-PACIFIC: CLINICAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 60: ASIA-PACIFIC: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 61: ASIA-PACIFIC: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 62: ASIA-PACIFIC: CLINICAL MICROBIOLOGY MARKET SIZE, BY DISEASE AREA, 2014-2021 (USD MILLION)
  • TABLE 63: JAPAN: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 64: CHINA: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: INDIA: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 66: ROAPAC: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 67: ROW: MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION, 2014-2021 (USD MILLION)
  • TABLE 68: ROW: CLINICAL MICROBIOLOGY MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 69: ROW: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: ROW: CLINICAL MICROBIOLOGY MARKET SIZE, BY DISEASE AREA, 2014-2021 (USD MILLION)
  • TABLE 71: TOP 5 PRODUCT APPROVALS, LAUNCHES, AND ENHANCEMENTS (2012-2016)
  • TABLE 72: TOP 5 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS (2012-2016)
  • TABLE 73: TOP 5 ACQUISITIONS (2012-2016)
  • TABLE 74: TOP 5 EXPANSIONS (2012-2016)

LIST OF FIGURES

  • FIGURE 1: RESEARCH DESIGN
  • FIGURE 2: CHINA AND INDIA HAD THE LARGEST TUBERCULOSIS PATIENT POPULATION DURING 2005-2014
  • FIGURE 3: GLOBAL PREVALENCE OF HIV INFECTIONS AMONG ADULTS (2014)
  • FIGURE 4: HEALTHCARE EXPENDITURE ACROSS MAJOR COUNTRIES: 2000-2013
  • FIGURE 5: HEALTHCARE EXPENDITURE ACROSS MAJOR REGIONS, 2000-2013
  • FIGURE 6: INCREASE IN GERIATRIC POPULATION, BY COUNTRY (2011-2030)
  • FIGURE 7: PERCENTAGE INCREASE IN GERIATRIC POPULATION, BY REGION (1980-2010 VS. 2010-2040)
  • FIGURE 8: INCREASE IN THE PROPORTION OF THE ELDERLY IN THE OVERALL POPULATION, BY COUNTRY (2011-2030)
  • FIGURE 9: SIGNIFICANT PUBLIC-PRIVATE INVESTMENTS AND FUNDING TO SUPPORT CLINICAL MICROBIOLOGY-BASED RESEARCHES IN EUROPE
  • FIGURE 10: MICROBIAL TESTING EXPECTED TO BE THE FASTEST-GROWING LIFE SCIENCE APPLICATION SEGMENT TILL 2021
  • FIGURE 11: NUMBER OF NEW PRODUCT LAUNCHES: CLINICAL MICROBIOLOGY MARKET (2012-2015)
  • FIGURE 12: BOTTOM-UP APPROACH: CLINICAL MICROBIOLOGY INSTRUMENTS MARKET
  • FIGURE 13: BOTTOM-UP APPROACH: CLINICAL MICROBIOLOGY REAGENTS & KITS MARKET
  • FIGURE 14: TOP-DOWN APPROACH: MICROBIOLOGY TESTING MARKET
  • FIGURE 15: TOP-DOWN APPROACH: CLINICAL MICROBIOLOGY MARKET
  • FIGURE 16: DATA TRIANGULATION
  • FIGURE 17: ASSUMPTIONS OF THE RESEARCH STUDY
  • FIGURE 18: GLOBAL MICROBIOLOGY TESTING MARKET SIZE, BY APPLICATION (2016 VS. 2021)
  • FIGURE 19: GLOBAL CLINICAL MICROBIOLOGY PRODUCTS MARKET SIZE, BY REGION (2016)
  • FIGURE 20: GLOBAL CLINICAL MICROBIOLOGY MARKET SIZE, BY DISEASE AREA (2016 VS. 2021)
  • FIGURE 21: CLINICAL MICROBIOLOGY MARKET SHARE, BY REGION (2016)
  • FIGURE 22: MARKET GROWTH OPPORTUNITIES IN THE MICROBIOLOGY TESTING INDUSTRY
  • FIGURE 23: PHARMACEUTICAL APPLICATIONS TO DOMINATE THE MICROBIOLOGY TESTING MARKET TILL 2021
  • FIGURE 24: MARKET GROWTH OPPORTUNITIES IN THE CLINICAL MICROBIOLOGY INDUSTRY
  • FIGURE 25: NORTH AMERICA IS EXPECTED TO DOMINATE CLINICAL MICROBIOLOGY MARKET, BY PRODUCT, IN 2016
  • FIGURE 26: LABORATORY INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY PRODUCTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 27: RESPIRATORY DISEASES TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY MARKET DURING THE STUDY PERIOD
  • FIGURE 28: CHINA AND INDIA TO BE THE FASTEST-GROWING MARKETS FOR CLINICAL MICROBIOLOGY PRODUCTS TILL 2021
  • FIGURE 31: EVOLUTION OF DIAGNOSTIC TECHNIQUES FOR PATHOGEN IDENTIFICATION (AS OF 2015)
  • FIGURE 32: PERCENTAGE CHANGE IN ANNUAL HEALTHCARE EXPENDITURE-DEVELOPED VS. DEVELOPING COUNTRIES (2005-2014)
  • FIGURE 33: VALUE CHAIN ANALYSIS: CLINICAL MICROBIOLOGY INSTRUMENTS (2015)
  • FIGURE 34: VALUE CHAIN ANALYSIS: CLINICAL MICROBIOLOGY REAGENTS AND KITS (2015)
  • FIGURE 35: PORTER'S FIVE FORCES ANALYSIS: CLINICAL MICROBIOLOGY MARKET (2015)
  • FIGURE 36: CLINICAL MICROBIOLOGY MARKET SEGMENTATION: BY PRODUCT
  • FIGURE 37: LABORATORY INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY INSTRUMENTS MARKET TILL 2021
  • FIGURE 38: INCUBATORS TO DOMINATE THE CLINICAL MICROBIOLOGY LABORATORY INSTRUMENTS MARKET DURING THE FORECAST PERIOD
  • FIGURE 39: MOLECULAR DIAGNOSTIC INSTRUMENTS TO DOMINATE THE CLINICAL MICROBIOLOGY ANALYZERS MARKET TILL 2021
  • FIGURE 40: PATHOGEN-SPECIFIC KITS TO COMMAND THE LARGEST SHARE OF THE CLINICAL MICROBIOLOGY REAGENTS MARKET
  • FIGURE 41: PHARMACEUTICAL APPLICATIONS TO DOMINATE THE GLOBAL MICROBIOLOGY TESTING MARKET TILL 2021
  • FIGURE 42: NORTH AMERICA TO DOMINATE THE GLOBAL MICROBIOLOGY FOOD TESTING APPLICATIONS MARKET TILL 2021
  • FIGURE 43: NORTH AMERICA TO DOMINATE THE GLOBAL MICROBIOLOGY ENVIRONMENTAL APPLICATIONS MARKET TILL 2021
  • FIGURE 44: RESPIRATORY DISEASES SEGMENT TO DOMINATE THE GLOBAL CLINICAL MICROBIOLOGY MARKET TILL 2021
  • FIGURE 45: NORTH AMERICA TO DOMINATE THE GLOBAL CLINICAL MICROBIOLOGY MARKET FOR SEXUALLY TRANSMITTED DISEASES TILL 2021
  • FIGURE 46: NORTH AMERICA TO DOMINATE THE CLINICAL MICROBIOLOGY MARKET FOR PERIODONTAL DISEASES TILL 2021
  • FIGURE 47: NORTH AMERICA: CLINICAL MICROBIOLOGY MARKET SNAPSHOT (2016-2021)
  • FIGURE 48: EUROPE: CLINICAL MICROBIOLOGY MARKET SNAPSHOT (2016-2021)
  • FIGURE 49: ASIA-PACIFIC: CLINICAL MICROBIOLOGY MARKET SNAPSHOT (2016-2021)
  • FIGURE 50: REST OF THE WORLD: CLINICAL MICROBIOLOGY MARKET SNAPSHOT (2016-2021)
  • FIGURE 51: PRODUCT DEVELOPMENT AND COMMERCIALIZATION: A KEY GROWTH STRATEGY ADOPTED BY MAJORITY OF MARKET PLAYERS (2012-2016)
  • FIGURE 52: GLOBAL CLINICAL MICROBIOLOGY MARKET SHARE, KEY PLAYER (2015)
  • FIGURE 53: INCREASING FOCUS ON INORGANIC STRATEGIES IS STIMULATING THE MARKET COMPETITION AMONG KEY PRODUCT MANUFACTURERS
  • FIGURE 54: KEY STRATEGIC DEVELOPMENTS: CLINICAL MICROBIOLOGY MARKET (2012-2016)
  • FIGURE 55: GEOGRAPHIC REVENUE MIX OF THE TOP MARKET PLAYERS (2015)
  • FIGURE 56: BIOMERIEUX S.A.: COMPANY SNAPSHOT
  • FIGURE 57: DANAHER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 58: BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT
  • FIGURE 59: CEPHEID: COMPANY SNAPSHOT
  • FIGURE 60: ABBOTT LABORATORIES, INC.: COMPANY SNAPSHOT
  • FIGURE 61: ALERE, INC.: COMPANY SNAPSHOT
  • FIGURE 62: BIO-RAD LABORATORIES INC.: COMPANY SNAPSHOT
  • FIGURE 63: F. HOFFMAN- LA ROCHE LTD.: COMPANY SNAPSHOT
  • FIGURE 64: BRUKER CORPORATION: COMPANY SNAPSHOT
  • FIGURE 65: HOLOGIC, INC.: COMPANY SNAPSHOT
Back to Top